and, on top of this, the company developed a trial for this "de-risked" product with "proven potency and efficacy" that was specifically designed to screen out patients who were not likely to respond well...and all the time they hid from us the debacle about the fraudulent withdrawn QUT research papers....
- Forums
- ASX - By Stock
- DLM
- Ann: Shareholder Update
Ann: Shareholder Update, page-8
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
LU7
Discover the strong preliminary feasibility of the Bécancour Lithium Refinery, showcasing resilience in a low pricing environment and a strategic plan to capitalize on future price recoveries
Add DLM (ASX) to my watchlist
(20min delay)
|
|||||
Last
3.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.227M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
DLM (ASX) Chart |
Day chart unavailable